Your browser doesn't support javascript.
loading
Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis.
Yang, Seokhun; Kang, Jeehoon; Hwang, Doyeon; Zhang, Jinlong; Jiang, Jun; Hu, Xinyang; Hahn, Joo-Yong; Nam, Chang-Wook; Doh, Joon-Hyung; Lee, Bong-Ki; Kim, Weon; Huang, Jinyu; Jiang, Fan; Zhou, Hao; Chen, Peng; Tang, Lijiang; Jiang, Wenbing; Chen, Xiaomin; He, Wenming; Ahn, Sung Gyun; Yoon, Myeong-Ho; Kim, Ung; Lee, Joo Myung; Ki, You-Jeong; Shin, Eun-Seok; Kim, Hyo-Soo; Tahk, Seung-Jea; Wang, Jian'an; Koo, Bon-Kwon.
Afiliação
  • Yang S; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Kang J; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Hwang D; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Zhang J; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Jiang J; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Hu X; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Hahn JY; Samsung Medical Center, Seoul, Republic of Korea.
  • Nam CW; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.
  • Doh JH; Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
  • Lee BK; Kangwon National University Hospital, Chuncheon, Gangwon-Do, Republic of Korea.
  • Kim W; Kyung Hee University Hospital, Seoul, Republic of Korea.
  • Huang J; Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Jiang F; Hangzhou Normal University Affiliated Hospital, Hangzhou, China.
  • Zhou H; The 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Chen P; The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Tang L; Zhejiang Hospital, Hangzhou, China.
  • Jiang W; The Third Clinical Institute Affiliated To Wenzhou Medical University, Wenzhou, China.
  • Chen X; Ningbo First Hospital, Ningbo, China.
  • He W; The Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
  • Ahn SG; Wonju Severance Christian Hospital, Wonju, Gangwon-Do, Republic of Korea.
  • Yoon MH; Ajou University Hospital, Suwon, Republic of Korea.
  • Kim U; Yeungnam University Medical Center, Daegu, Republic of Korea.
  • Lee JM; Samsung Medical Center, Seoul, Republic of Korea.
  • Ki YJ; Uijeongbu Eulji Medical Center, Uijeongbu, Gyeonggi-Do, Republic of Korea.
  • Shin ES; Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
  • Kim HS; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Tahk SJ; Ajou University Hospital, Suwon, Republic of Korea.
  • Wang J; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Koo BK; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
JAMA Netw Open ; 7(1): e2350036, 2024 01 02.
Article em En | MEDLINE | ID: mdl-38170524
ABSTRACT
Importance Treatment strategies for intermediate coronary lesions guided by fractional flow reserve (FFR) and intravascular ultrasonography (IVUS) have shown comparable outcomes. Identifying low-risk deferred vessels to ensure the safe deferral of percutaneous coronary intervention (PCI) and high-risk revascularized vessels that necessitate thorough follow-up can help determine optimal treatment strategies.

Objectives:

To investigate outcomes according to treatment types and FFR and IVUS parameters after FFR- or IVUS-guided treatment. Design, Setting, and

Participants:

This cohort study included patients with intermediate coronary stenosis from the Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in Patients With Intermediate Stenosis (FLAVOUR) trial, an investigator-initiated, prospective, open-label, multicenter randomized clinical trial that assigned patients into an IVUS-guided strategy (which recommended PCI for minimum lumen area [MLA] ≤3 mm2 or 3 mm2 to 4 mm2 with plaque burden [PB] ≥70%) or an FFR-guided strategy (which recommended PCI for FFR ≤0.80). Data were analyzed from November to December 2022. Exposures FFR or IVUS parameters within the deferred and revascularized vessels. Main Outcomes and

Measures:

The primary outcome was target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, and revascularization at 2 years.

Results:

A total of 1619 patients (mean [SD] age, 65.1 [9.6] years; 1137 [70.2%] male) with 1753 vessels were included in analysis. In 950 vessels for which revascularization was deferred, incidence of TVF was comparable between IVUS and FFR groups (3.8% vs 4.1%; P = .72). Vessels with FFR greater than 0.92 in the FFR group and MLA greater than 4.5 mm2 or PB of 58% or less in the IVUS group were identified as low-risk deferred vessels, with a decreased risk of TVF (hazard ratio [HR], 0.25 [95% CI, 0.09-0.71]; P = .009). In 803 revascularized vessels, the incidence of TVF was comparable between IVUS and FFR groups (3.6% vs 3.7%; P = .95), which was similar in the revascularized vessels undergoing PCI optimization (4.2% vs 2.5%; P = .31). Vessels with post-PCI FFR of 0.80 or less in the FFR group or minimum stent area of 6.0 mm2 or less or with PB at stent edge greater than 58% in the IVUS group had an increased risk for TVF (HR, 7.20 [95% CI, 3.20-16.21]; P < .001). Conclusions and Relevance In this cohort study of patients with intermediate coronary stenosis, FFR- and IVUS-guided strategies showed comparable outcomes in both deferred and revascularized vessels. Binary FFR and IVUS parameters could further define low-risk deferred vessels and high-risk revascularized vessels.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Estenose Coronária / Reserva Fracionada de Fluxo Miocárdico / Placa Aterosclerótica / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Netw Open Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Estenose Coronária / Reserva Fracionada de Fluxo Miocárdico / Placa Aterosclerótica / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Netw Open Ano de publicação: 2024 Tipo de documento: Article